SVision Imaging rebrands as Intalight, expands offerings with DREAM OCT platform

Ophthalmic technology firm SVision Imaging is expanding its role in OCT imaging devices under the new name Intalight Inc., the company announced in a press release.

The company, which in 2019 released one of the first swept-source OCT devices, has named Joe Garibaldi as chief commercial officer, the release stated.

 

“I’m honored to be leading the Intalight U.S. operation,” Garibaldi, founder of West Coast Ophthalmic Instruments & Consulting and former vice president of global commercialization at Optovue, said in the release. “This company was built on bringing innovative technology to those who need it most, and I’m excited to be part of the team that pushes the limit of technologies to empower eye care professionals and benefit patients.”

 

According to the release, Intalight is in the process of submitting a 501(k) for its DREAM OCT platform, which stands for deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection and multimodal imaging capabilities. The DREAM OCT Swept-Source 12 mm scanning provides high-quality imaging of the choroid and retina and a large portion of the vitreous space, the company stated, and can image the complete anterior segment of the cornea to the anterior part of the vitreous in one scan with its 16.2-mm range.

 

“We have been perfecting this state-of-the art technology for several years, and we’re excited to bring it to the U.S. market with the expertise of Joe Garibaldi leading the way,” Shawn Peng, founder and president of Intalight, said in the release. “With DREAM OCT, Intalight is truly providing the ultimate solution for eye care professionals to see wider and deeper OCTA and traditional OCT images, which deliver accurate results in repeatability to assist with improved disease management for patients.”